An update from InMed Pharmaceuticals (INM) is now available.
The Company recently shared its third-quarter financial performance and business developments, ending March 31, 2024. This newly released financial update provides investors with a fresh look at the company’s progress but is not intended for legal filing purposes under the Securities Exchange Act of 1934. Investors looking for the latest insights into the company’s financial health will find this update particularly informative.
See more insights into INM stock on TipRanks’ Stock Analysis page.
